Ameni Gouider | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Ameni Gouider | Formulation Science | Best Researcher Award

Faculty of Sciences of Gabes | Tunisia

Ms. Ameni Gouider is an emerging researcher in electrochemical water treatment and environmental chemistry, dedicated to developing sustainable solutions for the remediation of industrial effluents, particularly from the pharmaceutical sector. She is currently pursuing a Doctorate in Water Treatment by Electrochemistry at the Faculty of Sciences of Gabès, Tunisia, where her research centers on advanced electrochemical processes for treating pharmaceutical wastewater. Her doctoral work reflects a deep commitment to environmental protection and technological innovation, with a focus on optimizing electrochemical and membrane-based systems for effective pollutant removal.As part of her ongoing research, Ms. Gouider is conducting a research internship at the CNRS / Institut Européen des Membranes in Montpellier, France. Her current project explores the integration of electrochemical and membrane technologies for the depollution of complex industrial effluents, bridging the gap between laboratory research and real-world environmental applications. Her scientific curiosity and methodological precision allow her to design, test, and model innovative approaches that contribute to the global effort toward sustainable water management.Ms. Gouider holds a Master’s degree in Materials and Environmental Chemistry and a National License in Chemistry from the Faculty of Sciences of Gabès, following a solid foundation in experimental sciences acquired during her early studies. Her academic path has equipped her with strong analytical, experimental, and statistical skills, including expertise in advanced experimental design, response surface methodology, multivariate optimization, and analysis of variance (ANOVA). She is proficient in using specialized software such as Nemrod and Microsoft Office tools for data analysis, scientific reporting, and presentation.Her publication titled “Treatment of pharmaceutical industry effluent using conventional and pulsed electrocoagulation on iron electrodes: Optimization using response surface methodology” published in Total Environment Engineering (Elsevier) highlights her innovative approach in applying electrochemical methods to optimize effluent treatment processes. This work demonstrates her ability to combine theoretical modeling with experimental validation to enhance the performance and sustainability of industrial water treatment systems.Ms. Gouider’s research has been presented at several national and international scientific events, including Euro-Africa Congresses and water-related scientific forums, where she actively contributes to discussions on environmental protection and technological advancement. Known for her organizational skills, teamwork, and dedication, she continues to pursue excellence in scientific communication, applied research, and interdisciplinary collaboration, driven by her vision of creating cleaner technologies for a sustainable future.

Profile: Orcid

Featured Publications

Gouider, A., Zaabtia, A., Khalifa, M., Ba, M., & Ammar, S. (2025). Treatment of pharmaceutical industry effluent using conventional and pulsed electrocoagulation on iron electrodes: Optimization using response surface methodology. Total Environment Engineering, 100048.

Faiza Abou El-Soud | Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Faiza Abou El-Soud | Formulation Science | Best Researcher Award

College of Nursing-Riyadh King Saud bin Abdulaziz University for Health Sciences | Saudi Arabia

Prof. Faiza Abou El-Soud is a distinguished scholar and nursing educator whose work focuses on advancing health outcomes, improving the quality of patient care, and enriching the academic development of nursing students. With extensive expertise in nursing education, geriatric care, and psychosocial health, Professor Abou El-Soud has built a research portfolio that bridges theoretical understanding with practical application in healthcare and nursing practice. Her scholarly contributions reflect a commitment to evidence-based nursing, patient-centered care, and the empowerment of healthcare professionals through research-driven insights.Among her notable works is Nursing Students’ Perceptions toward Success and Failure Factors and their Academic Performance: A Descriptive Correlational Study, published in SYLWAN, which explores the academic determinants influencing nursing students’ success, offering valuable perspectives for educators seeking to improve nursing education outcomes. Another significant contribution, Impact of Self-Efficacy Theory on Improving Adherence of Older Adults Patients with Glaucoma’s Medication, published in the Journal of Health, Medicine and Nursing, applies psychological theory to practical nursing interventions, highlighting how self-efficacy principles can enhance medication adherence among older adults suffering from glaucoma.Professor Abou El-Soud has also made important contributions to geriatric health and community nursing through her publication Quality of Life, Self-Rated Health and Social Support among Older Adult in the Saudi Community in The Malaysian Journal of Nursing, where she and her co-authors assess the complex interplay between social support, perceived health, and overall life satisfaction among elderly populations. In another influential study, The Relationship between Health-Related Quality of Life and Burden among Family Caregivers of Elderly Patients Undergoing Hemodialysis in Saudi Arabia, published in the International Journal of Nursing Research, she investigates the emotional and physical challenges faced by caregivers, offering actionable insights to enhance support systems and healthcare strategies.Her collaborative work Impact of the Intrinsic and Extrinsic Motivation Factors on the Turnover Intention among Academic Staff, published in the IOSR Journal of Nursing and Health Science, examines motivational dynamics in academic environments and their influence on faculty retention, thereby contributing to the sustainability and advancement of nursing education institutions.

Profile: Google Scholar

Featured Publications

Salama, R. A., & Abou El-Soud, F. A. (n.d.). Caregiver burden from caring for impaired elderly: A cross-sectional study in rural Lower Egypt. Italian Journal of Public Health, 9(4), 103.

AlAnnaz, W. A. A., Gouda, A. D. K., Abou El-Soud, F. A., & Alanazi, M. R. (n.d.). Obesity prevalence and its impact on maternal and neonatal outcomes among pregnant women: A retrospective cross-sectional study design. Nursing Reports, 14(2), 1236–1250.

Hussein, A. A., & El-Soud, F. A. A. (n.d.). Developing an educational intervention and a standardized clinical assessment tool to promote clinical instructors assessment skills. The Fifteenth National Conference Evidence Based Practice.

Shaqiqi, W., & Abou El-Soud, F. A. (n.d.). The mediating role of social support on the relationship between secondary traumatic stress and burnout of nurses caring for COVID-19 patients: A cross-sectional study. Applied Nursing Research, 79, 151844.

Abou El-Soud, F. A., Alhoraim, S. A., Alammar, B. A., & Alotaibi, R. S. (n.d.). Quality of life, self-rated health and social support among older adult in the Saudi community. The Malaysian Journal of Nursing, 11(3), 13–25.

Al-Shehhi, M. S. M., & El-Soud, F. A. A. (n.d.). Factors affecting quality of life in patients with end-stage renal disease on hemodialysis, Ras Al Khaimah – United Arab Emirates. Journal of Health, Medicine and Nursing, 220–238.

Abou-El-Soud, F. A., Mohamed, H. F., & Prince, J. (n.d.). The effectiveness of training workshop in changing the tutors’ knowledge and attitude towards the integration of problem-based learning into nursing curriculum. International Journal of Nursing, 5.

Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Song Guo Zheng | Drug Discovery and Development | Best Researcher Award

Chair Professor at Shanghai Jiao Tong University School of Medicine | China

Prof. Song Guo Zheng, M.D., Ph.D., is an internationally renowned immunologist and clinician-scientist specializing in rheumatology, molecular immunology, and translational medicine. He currently serves as Chair Professor and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University. With academic leadership roles across prestigious institutions in the U.S. and China, his pioneering work spans autoimmunity, cell therapy, and immunoregulation. A prolific author with over 110 peer-reviewed publications in top-tier journals, Prof. Zheng is also a highly decorated researcher and active leader in global immunology societies. His contributions continue to shape modern immunotherapy and precision medicine.

Publication Profile 

Google Scholar

Orcid

Education 

Prof. Zheng earned his Ph.D. in Molecular Immunology from the University of Orleans, France (2011), and a Master’s in Pathology and Immunology from Shanghai Medical University (1992). He completed his M.D. at Anhui Medical University (1984). His clinical training included a residency in surgery at Chizhou City Hospital (1984–1989) and an internship at Shanghai Zhabei Hospital (1983–1984). He further pursued a pathology fellowship at Shanghai Medical University Cancer Hospital (1989–1993). These academic and clinical foundations laid the groundwork for a distinguished career in immunology, clinical research, and translational medicine across both China and the United States.

Experience 

Prof. Zheng currently serves as Chair Professor at Shanghai Jiao Tong University and Dean of the School of Cell and Gene Therapy (2023–Present). He previously held senior positions including the Ronald L. Whisler Chair in Rheumatology and Immunology at Ohio State University (2018–2022) and Director at Penn State University’s College of Medicine (2013–2018). His U.S. academic journey began at the University of Southern California as an assistant and associate professor (2004–2013), after postdoctoral work at USC and UCLA. With leadership in research, teaching, and clinical science, he has become a global authority in immunological therapeutics and rheumatology.

Awards

Prof. Zheng has received numerous prestigious honors, including the Outstanding Scientist Award (2023, USA) and the Distinguished Clinical Immunologist Award (2019, China). He was awarded the Edmund L. Dubois Award (2019), NIH STAR Award (2016–2021), and was Chair of NIH MOSS Study Section (2016). Notably, he earned the James R. Klinenberg Award for best immunologist in Southern California (2007) and the Freda Newton Memorial Scholar Award (2006). He is an elected member of The Henry Kunkel Society (2012) and a recipient of the ACR Investigator Award (2008–2010), reflecting his impactful and sustained contributions to clinical immunology.

Research Focus 

Prof. Zheng’s research centers on molecular immunology, particularly in autoimmune diseases, Treg/Th17 cell modulation, and immune tolerance mechanisms. He investigates immunometabolism, gene and cell therapy, and inflammatory signaling pathways with an emphasis on clinical translation. His studies on cytokines, nanomedicine, and immune checkpoint regulation aim to advance precision therapeutics for rheumatic and inflammatory diseases. He integrates cutting-edge techniques including single-cell sequencing, CRISPR-based modulation, and nano-drug delivery systems. His innovative research is highly cited and supports next-generation treatments for autoimmunity, cancer immunotherapy, and organ-specific inflammation, shaping global trends in immune-based medical interventions.

Publication Top Notes

Natural and induced CD4+ CD25+ cells educate CD4+ CD25− cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10

IL-2 is essential for TGF-β to convert naive CD4+ CD25− cells to CD25+ Foxp3+ regulatory T cells and for expansion of these cells

Role of vitamin A in the immune system

Generation ex vivo of TGF-β-producing regulatory T cells from CD4+ CD25− precursors

Vitamin D and chronic diseases

TGF-β requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+ CD25+ regulatory cells

Natural and TGF-β–induced Foxp3+ CD4+ CD25+ regulatory T cells are not mirror images of each other

Role of TNF–TNF receptor 2 signal in regulatory T cells and its therapeutic implications

Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF-β are resistant to Th17 conversion by IL-6

Hall of fame among pro-inflammatory cytokines: interleukin-6 gene and its transcriptional regulation mechanisms

The ubiquitin ligase Stub1 negatively modulates regulatory T cell suppressive activity by promoting degradation of the transcription factor Foxp3

The role of the combination of IL-2 and TGF-β or IL-10 in the generation and function of CD4+ CD25+ and CD8+regulatory T cell subsets

Conclusion

Given his outstanding scientific productivity, leadership in global immunology communities, and groundbreaking research on immune regulation, Prof. Song Guo Zheng is highly suitable for the Best Researcher Award. His body of work demonstrates not only scientific depth and innovation but also sustained impact on the field of immunology and clinical medicine. With ongoing contributions and strategic improvements, he remains a central figure in advancing immune-based therapies and education worldwide.

E Marimuthu | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. E. Marimuthu | Drug Discovery and Development | Best Researcher Award

Professor at Arunachal University of Studies | Ayya Nadar Janaki Ammal College | Madurai Kamaraj University | India

Dr. E. Marimuthu is a dedicated researcher and academician specializing in plant biotechnology, microbiology, and molecular biology. With over 15 years of experience in research and education, he has made significant contributions through patents, microbial sequencing, and ethnobotanical surveys. His work focuses on endangered species conservation, natural IAA production, and nanomedicine applications for cancer. Dr. Marimuthu currently serves as a Professor at Arunachal University of Studies. His multidisciplinary efforts bridge traditional knowledge with modern scientific innovations, making him a standout figure in applied life sciences and pharmaceutical biotechnology.

Publication Profile 

Scopus 

Education

Dr. Marimuthu earned his Ph.D. from Madurai Kamaraj University in 2017, focusing on the in vitro conservation of endangered tree species in the Southern Western Ghats . He completed his M.Phil. and M.Sc. from Ayya Nadar Janaki Ammal College, conducting ethnomedicinal surveys and plant growth hormone studies. His academic foundation began with a B.Sc. in Botany. Each academic milestone has been rooted in biodiversity conservation and plant-microbe interactions, establishing a strong base for his later patents and microbial gene discoveries .

Experience

Dr. Marimuthu has held various academic and research roles: Professor and Associate Professor at Arunachal University of Studies (2023–present), Assistant Professor at Sri Vidya Mandir and Vivekanandha Colleges, and Associate Scientist at Aakash Green Research Pvt. Ltd. Earlier, he served as a JRF at TBGRI, Kerala  and Technical Assistant at Kalasalingam University. His experience spans plant tissue culture, cell line work, and microbial molecular studies. With deep involvement in both lab and field research, he has nurtured innovations from concept to patent, while also mentoring students and contributing to curriculum development.

Awards 

Dr. E. Marimuthu is a prolific innovator with 8 Indian patents and 2 Canadian patents, showcasing breakthroughs in nanomedicine, cancer immunotherapy, and plant-based biotechnology . His bacterial gene sequences are submitted to NCBI, emphasizing novel microbial discoveries from unique ecological niches. Recognized nationally and internationally for his translational research, he has pioneered techniques that merge traditional plant knowledge with high-end scientific platforms. Though specific named awards are not listed, his patent record and academic promotions signify a distinguished and respected trajectory in bioscience innovation and interdisciplinary research.

Research Focus 

Dr. Marimuthu’s research emphasizes plant tissue culture, natural growth hormone production, ethnomedicinal conservation, and nanotechnology-enhanced drug delivery . He explores molecular markers for documenting genetic diversity and has successfully isolated bacterial strains producing Indole-3-acetic acid (IAA) to promote plant growth . He integrates ethnobotanical knowledge with biotechnological advancements to develop eco-friendly, scalable solutions for agriculture and medicine. His cutting-edge work in cancer-targeting mesenchymal stem cell therapy, as well as nano-immunotherapy, reflects a visionary outlook on the future of personalized medicine and sustainable pharmacology.

Publication Top Notes

Title: Chemical profiling and in silico molecular docking studies of phytochemicals from Hydnocarpus macrocarpa Warb: A GC–MS, FTIR, and physico-chemical analysis
Journal: Journal of Molecular Structure
Year: 2025

Conclusion

Dr. E. Marimuthu is an outstanding candidate for the Best Researcher Award, showcasing a rare combination of field knowledge, lab precision, patent-oriented innovation, and a commitment to both fundamental and applied science. His work contributes significantly to biotechnology, pharmacology, environmental microbiology, and regenerative agriculture.

SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Published on by Top Pharmaceutical

SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Prof. Dr. SILVIA MARIA DÍAZ PRADO, University of A Coruña, Spain

Prof. Dr. Silvia María Díaz Prado is a Professor of Anatomy at the University of A Coruña and leads the Cellular Therapy and Regenerative Medicine Group at INIBIC. With a PhD in Biology (2004), her research spans tissue engineering, stem cells 🧬 (including iPSCs), novel biomaterials, 3D bioprinting 🖨️, and nanoparticle drug delivery 💊. She has published 68 articles (H-index: 24), 32 book chapters, and presented at 215 conferences. Dr. Díaz Prado has led 33 research projects, supervised over 50 theses, and received 7 research awards 🏅. She coordinates the Master’s in Health Care and Research program.

Publication Profile

Google Scholar

Education

Prof. Dr. Silvia María Díaz Prado 🎓 holds a Ph.D. in Biology (2004) from the University of A Coruña, where she serves as a Professor of Anatomy 🧠 and coordinates the Master’s Degree in Health Care and Research 💉📚. With a distinguished academic career, she has played a pivotal role in shaping advanced medical education and fostering scientific inquiry 🔬. Her dedication to teaching and mentorship has inspired countless students and researchers, reinforcing her status as a respected leader in the biomedical field 🌟. Prof. Dr. Díaz Prado continues to advance excellence in health sciences through education and innovation.

Awards

Prof. Dr. Silvia María Díaz Prado 🏅 has been honored with seven prestigious research awards 🧪, reflecting the high regard in which her scientific contributions are held by the academic community 🌍. These accolades underscore her exceptional merit, dedication to innovation, and impactful work in the field of biomedical research 🧬. Each award stands as a testament to her relentless pursuit of knowledge, excellence, and advancement in science 🔍✨. Prof. Díaz Prado’s achievements not only bring recognition to her individual efforts but also elevate the institutions and research teams she represents, inspiring future generations of scientists 🎓🌟.

Research Focus

Prof. Dr. Silvia María Díaz-Prado is a distinguished researcher in the field of Regenerative Medicine 🧬🦴, with a strong focus on stem cells, cartilage repair, and molecular signaling in musculoskeletal disorders. Her groundbreaking work explores microRNA profiling🧪, mesenchymal stem cells🧫, and the human amniotic membrane as a novel source for cell therapy. She also investigates oncogenic pathways like Wnt, Notch, and Hedgehog 🔬, linking them to cancer stem cells. Prof. Díaz-Prado’s contributions bridge molecular biology with clinical applications, making her a key figure in orthopedic tissue engineering, biomarkers, and cell-based therapeutic strategies.

Publication Top Notes

Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes

Cloning genes from a library using a clustering strategy and PCR

Multilineage differentiation potential of cells isolated from the human amniotic membrane

Human amniotic membrane as an alternative source of stem cells for regenerative medicine

Wnt signalling and cancer stem cells

Notch signalling in cancer stem cells

Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair

Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes

Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

Isolation and characterization of mesenchymal stem cells from human amniotic membrane

Induced pluripotent stem cells for cartilage repair: current status and future perspectives

Biology of BMP signalling and cancer

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Published on by Top Pharmaceutical

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Ms. Oliwia Kordyl, Poznan Univeristy of Medical Sciences, Poland

Ms. Oliwia Kordyl (b. June 9, 1997) is a dedicated PhD student at Poznan University of Medical Sciences, specializing in 3D printed microneedles for targeted drug delivery. With a background in biotechnology from Adam Mickiewicz University, her work spans molecular biology, pharmaceutical technology, and reproductive genetics. Oliwia has held roles as a lab manager, molecular biologist, and biotechnologist, contributing to innovative projects and scientific conferences. She is skilled in advanced lab techniques and passionate about travel, fitness, and continuous learning.

Publication Profile

orcid

Education

Ms. Oliwia Kordyl is currently pursuing her Ph.D. (Nov 2023–Present) at the Poznan University of Medical Sciences in Poland, focusing on 3D printed microneedles for voriconazole delivery in treating local skin infections. Her research involves optimizing microneedle manufacturing, assessing physicochemical and pharmaceutical properties in vitro, and evaluating drug permeation ex vivo and microbiological effectiveness 🧪🧬. She earned her M.Sc. and B.Sc. in biotechnology from Adam Mickiewicz University (2016–2021), where she explored DNA methylation in oligozoospermia and gene expression in spermatogenesis 🧫. Her academic journey began at K.K. Baczyński Secondary School, specializing in biology, physics, and chemistry 🔬📚.

Experience

Ms. Oliwia Kordyl completed a valuable internship at Novazym Polska in Poznań from July to August 2019. During her time at this renowned biotechnology company, she gained hands-on experience in laboratory techniques and deepened her understanding of industrial biotechnology practices 🔬💼. The internship provided her with practical insights into the daily operations of a biotech firm and allowed her to apply her academic knowledge in a real-world setting 🧪📊. This experience not only enhanced her technical skills but also strengthened her passion for research and innovation in the field of biotechnology, laying a strong foundation for her future scientific endeavors 🚀.

Awards

🏆 Ms. Oliwia Kordyl has actively contributed to the scientific community through speeches and posters at esteemed conferences. She presented on sperm DNA methylation at the 21st Andrology Day (2019) 🧬 and the 21st European Testis Workshop (2021) in Barcelona. Her posters featured at ESHRE 2020, the European Human Genetics Conference (2021), and the 6th Polish Congress of Genetics (2022) showcased her expertise in epigenetics and sperm chromatin structure 🧫📊. In 2023, she co-authored a poster on microneedles for transdermal drug delivery at PolGerSym10 💉. Oliwia also co-authored a publication in the International Journal of Molecular Sciences (2022) 📄📚.

Research Focus

Ms. Oliwia Kordyl’s research focuses on the development of innovative drug delivery systems, particularly microneedle-based technologies for transdermal applications. Her work combines 3D printing, pharmaceutical coatings, and hydrogel systems to enhance the treatment of bacterial and fungal skin infections. She also explores photodynamic therapy and nanotechnology for targeted drug release. Her interdisciplinary approach bridges materials science, biomedical engineering, and pharmaceutics. Additionally, her research extends to epigenetic analysis in human sperm, highlighting her interest in reproductive biology. Her work is at the frontier of personalized medicine, non-invasive therapies, and advanced pharmaceutical technologies.

Publication Top Notes

Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems

Microneedle-based arrays – Breakthrough strategy for the treatment of bacterial and fungal skin infections

Microneedle System Coated with Hydrogels Containing Protoporphyrin IX for Potential Application in Pharmaceutical Technology

Global 5mC and 5hmC DNA Levels in Human Sperm Subpopulations with Differentially Protaminated Chromatin in Normo- and Oligoasthenozoospermic Males

Yu Liu | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Yu Liu | Drug Discovery and Development | Best Researcher Award

Mr. Yu Liu, China Institute of Pharmaceutical Industry Co., Ltd, China

Dr. Liu Yu (b. January 11, 1981, Hengyang, Hunan) is a distinguished researcher and doctoral supervisor specializing in medicinal chemistry. He earned his Ph.D. from the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (2011). Currently, he serves as Deputy Director at the China National Institute for the Control of Pharmaceutical and Biological Products and the Shanghai Drug Synthesis Process Engineering Technology Research Center. He is also a standing committee member of the Health Economics Theory and Policy Committee. Dr. Liu plays a pivotal role in pharmaceutical research and technology transfer in China.

Publication Profile

Scopus

Education

Mr. Yu Liu pursued his education in Medicinal Chemistry 🧪 at the Shanghai Institute of Materia Medica, Chinese Academy of Sciences 🎓. He was enrolled as a full-time student from September 2008 to July 2011 📅. During this period, he dedicated himself to advanced research in the field, ultimately earning a Doctorate degree 🎖️. His studies focused on the development of medicinal compounds and pharmaceutical innovations, contributing to the field of drug discovery and development 💊. With a strong academic foundation, Mr. Liu gained expertise in chemical synthesis and pharmacology, preparing him for a successful career in medicinal sciences 🔬.

Professional Leadership

Mr. Yu Liu serves as the Deputy Director 🏛️ at both the Technology Transfer Center, China National Institute for the Control of Pharmaceutical and Biological Products and the Shanghai Drug Synthesis Process Engineering Technology Research Center 🔬. In these roles, he plays a pivotal part in advancing pharmaceutical and biotechnology research 💊. His leadership drives innovation in drug development and synthesis, ensuring progress in the field of medicinal chemistry 🧪. With his extensive expertise, Mr. Liu significantly contributes to technology transfer, regulatory advancements, and pharmaceutical innovation, reinforcing his influence in the global healthcare industry 🌍.

Experience

Mr. Yu Liu is an esteemed member of high-level academic committees 🏛️, including the Standing Committee of the Health Economics Theory and Policy Professional Committee under the Chinese Association of Health Economics 📊. His active participation in these organizations reflects his dedication to bridging scientific innovation and economic policy in healthcare 💡💰. By contributing to policy development and strategic decision-making, he plays a crucial role in shaping the future of health economics and pharmaceutical advancements 💊. His interdisciplinary expertise ensures a significant impact on both scientific research and economic frameworks, fostering innovation in healthcare systems 🌍.

Research Focus

Yu Liu’s research focuses on analytical chemistry, particularly in pharmaceutical analysis. His expertise lies in the development and validation of advanced chromatographic techniques, such as GC (Gas Chromatography) and HPLC-RID (High-Performance Liquid Chromatography with Refractive Index Detection). His work involves identifying and quantifying related substances in pharmaceutical compounds, including novel impurities in tetrabenazine. His contributions ensure drug purity, safety, and efficacy, making a significant impact on quality control and regulatory compliance in the pharmaceutical industry. His research bridges analytical chemistry and pharmaceutical sciences, advancing drug formulation and safety.

Publication Top Notes

GC and HPLC-RID method development and validation for the determination of twelve related substances, including several novel compounds in tetrabenazine

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Bekri Melka Abdo | Drug Discovery and Development | Top Pharmaceutical Scientist Award

Mr. Bekri Melka Abdo, Ethiopian Institute of Agricultural Research, Ethiopia

Bekri Melka Abdo is a dedicated organic chemist specializing in natural product chemistry 🌿. With expertise in plant sample collection, extraction, compound isolation, and structure elucidation, he focuses on bioactive compounds from Ethiopia’s medicinal and aromatic plants. His research contributes to developing natural product-based treatments for leishmaniasis 🦠. He has two published journal articles, an h-index of 7, a Google patent, and an ISBN-registered book 📖. Actively engaged in research and consultancy, Bekri is committed to innovative drug discovery and advancing natural product chemistry for global health.

Publication Profile

orcid

Education

Bekri Melka Abdo is a dedicated professional in organic chemistry 🧪, specializing in natural product chemistry 🌿. His expertise encompasses plant sample collection and preparation, extraction, compound isolation, and structure elucidation. He is skilled in qualitative and quantitative analysis, as well as biological activity determination of natural products extracted from various aromatic and medicinally significant 🌱 exotic and endemic plant species of Ethiopia. With a strong foundation in the field, he contributes to the discovery and characterization of bioactive compounds, supporting advancements in medicine, pharmaceuticals, and biotechnology 🔬. His research plays a vital role in exploring Ethiopia’s rich botanical resources.

Experience 

Bekri Melka Abdo is a passionate researcher in natural product chemistry 🌿, with a strong track record of research and innovation 🔬. He has successfully completed two research projects and maintains an h-index of 7 📊. His contributions extend to industry consultancy and collaborative projects, showcasing his impact in the field. He has authored a book with an ISBN 📖 and has a Google patent pending. His work is recognized in SCI and Scopus-indexed journals 🏅, with two publications. Actively engaged in editorial roles and professional memberships, he continues to drive scientific advancements in bioactive compound discovery.

Award

Bekri Melka Abdo, with his early career achievements and promising research in natural product chemistry 🌿, is an ideal candidate for the Young Scientist Award 🏆. His dedication to bioactive compound discovery, coupled with his impactful contributions to scientific research and innovation 🔬, highlights his potential for future breakthroughs. With a strong foundation in natural product extraction, analysis, and biological activity determination, he is paving the way for new discoveries in medicine and biotechnology 💊. This award category recognizes emerging researchers like Mr. Abdo, whose work demonstrates both excellence and the promise of transformative scientific advancements.

Research Focus

Mr. Bekri Melka Abdo specializes in phytochemistry and antiparasitic drug discovery, focusing on the bioassay-guided isolation of natural compounds for therapeutic applications. His research on dehydrocostus lactone from Echinops kebericho highlights its potential as a leishmanicidal drug 🦟⚕️. His work integrates natural product chemistry, pharmacognosy, and infectious disease research, contributing to novel drug development against leishmaniasis. By combining traditional medicinal plants with modern bioassays, he advances the search for effective, plant-derived antiparasitic treatments 🌱🔬. His research holds promise for addressing neglected tropical diseases through sustainable and nature-inspired therapies.

Publication Top Notes

Bioassay-guided isolation of dehydrocostus lactone from Echinops kebericho as a leishmanicidal drug

Alberto Leyva | Biopharmaceutics | Best Researcher Award

Published on by Top Pharmaceutical

Alberto Leyva | Biopharmaceutics | Best Researcher Award

Prof. Alberto Leyva, Center for Genetic Engineering and Biotechnology, Cuba

🔬 Prof. Alberto Leyva Gálvez (b. September 18, 1976) is a Cuban microbiologist and expert in biopharmaceutical systems. 🎓 He holds a Master’s in Science and has served at the Center for Genetic Engineering and Biotechnology since 2003. 🏭 As Head of Critical Systems, he specializes in analytical validation, antibody purification, and regulatory compliance. 📑 With 18 scientific publications, he has led key projects in water treatment, system validation, and quality assurance. 🏅 A dedicated educator, he conducts training in biotechnology, validation, and risk management. His expertise ensures excellence in biopharmaceutical production and regulatory standards. ✅

Publication Profile

Education

Professor Alberto Leyva is a distinguished microbiologist with a strong academic and research background. He earned his Licenciado en Microbiología degree in 2003 from the Universidad de la Habana 🎓 and later obtained a Master en Ciencias. Currently, he serves as an Investigador Auxiliar 🧪 and holds the title of Tecnólogo de I Nivel in the field of biotechnology. Since September 2003, he has been contributing to groundbreaking research at the Centro de Ingeniería Genética y Biotecnología 🔬, where he continues to advance scientific knowledge. His dedication to microbiology and biotechnology makes him a key figure in his field.

Professional Experience 

Professor Alberto Leyva has extensive experience in microbiology and biotechnology, specializing in immunochemical techniques and analytical method validation 🧪. He has worked on antibody purification through affinity columns and has authored 18 scientific articles in international journals 📚. His expertise includes design, qualification, and validation of critical systems such as water, pure steam, and compressed air 💧. He has conducted FAT and SAT testing and participated in regulatory inspections . Additionally, he has contributed to water recovery and reuse in production plants and managed critical and auxiliary systems ⚙️. He also teaches courses on validation and maintenance in biopharmaceutical industries.

Global Scientific Influence

Professor Alberto Leyva has made a significant impact on the global scientific community through his publications in internationally recognized journals 🌍📚. His research contributions in pharmaceutical, biotechnological, and regulatory fields have been widely cited, reflecting his influence on industry practices and scientific advancements 🧪💊. Being fluent in Spanish and English 🗣️, he actively engages with researchers worldwide, fostering international collaborations 🤝. His expertise extends beyond academia, shaping biopharmaceutical innovations and regulatory standards . Through his dedication and global reach, he continues to drive progress in microbiology and biotechnology, leaving a lasting mark on the scientific world.

Industry Impact

Professor Alberto Leyva has made a profound impact on the biopharmaceutical industry through his expertise in monoclonal antibodies, recombinant protein quantification, and process control 🧪💊. His research plays a crucial role in healthcare advancements by ensuring precision in pharmaceutical production. Additionally, his work on water purification, air quality validation, and critical system design contributes to maintaining high industry standards 💧. The practical applications of his research extend beyond academia, directly influencing industrial biotechnology and pharmaceutical innovations. His dedication to quality and efficiency continues to shape global biopharmaceutical manufacturing and regulatory practices.

Research Focus

Professor Alberto Leyva specializes in biopharmaceutical analysis 🧪, with a research focus on stability-indicative assays and conformation-specific immunoassays 🧬 for biologics, particularly recombinant human gamma interferon (rhIFN-γ) 💉. His work involves developing enzyme-linked immunosorbent assays (ELISA) 🏥 to assess the stability, integrity, and conformational changes of therapeutic proteins. This research is crucial for biopharmaceutical quality control 🔬, ensuring the efficacy and safety of protein-based drugs. His expertise spans protein characterization, immunoassay development, and biologics stability testing, contributing to regulatory compliance 📜 and the advancement of precision medicine .

Publication Top Notes

Stability-indicative and conformation-specific enzyme linked immunosorbent assay for analysis of recombinant human gamma interferon

Yuzhu Cai | Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Yuzhu Cai | Pharmacology | Best Researcher Award

Dr. Yuzhu Cai, Beihang University, China

Dr. Yuzhu Cai is a dedicated researcher in software engineering, currently pursuing a Ph.D. at Beihang University, China. He earned his Bachelor’s degree in Information Security with a Mathematics minor from Nankai University. An award-winning innovator, he has secured top honors in national competitions, including cryptography, algorithm design, and mathematical modeling. His research spans AI ethics, cybersecurity, and password security, with notable publications in Cell Patterns and ICLR 2025. Co-founder of Han Hai Xing Tu Technology, he pioneers AI-driven educational platforms. His contributions in cryptography and AI showcase his passion for innovation and security. ✨📊

Publication Profile

Education

Dr. Yuzhu Cai 🎓 is a dedicated scholar in the field of software engineering. He is currently pursuing his Ph.D. in Software Engineering at Beihang University, Tianjin, China (Sept 2024 – Present) 🖥️. Prior to this, he earned his Bachelor of Science in Information Security from Nankai University (Sept 2020 – Jul 2024) 🔐. Alongside his major, he also pursued a Minor in Mathematics (Sept 2021 – June 2023) ➗, further strengthening his analytical skills. With a strong academic foundation and a passion for innovation, Dr. Cai continues to advance in the field of technology and cybersecurity.

Awards

Dr. Yuzhu Cai 🎖️ has received numerous prestigious awards for his excellence in information security, cryptography, and mathematics. He secured First Prize in the National Information Works Competition 🏆, along with the Most Innovative and Entrepreneurial Value Award. He also won First Prize in the 7th National Cryptography Technology Competition 🔐 and the National College Students’ Mathematical Modeling Competition (Tianjin Area) 📊. His achievements include a Bronze Medal in the National Algorithm Design and Programming Challenge 💻 and First Prize in the Tianjin Electronic Design Competition. Additionally, he earned multiple scholarships 🏅, including Nankai University’s Public Ability and Innovation Scholarships. 🚀

Scientific Contributions

Dr. Yuzhu Cai 🧑‍🔬 has made remarkable contributions to the field of artificial intelligence and cybersecurity. He has co-authored influential publications in top-tier journals like Cell Patterns 📄 and presented groundbreaking research at ICLR 2025 🤖, focusing on AI ethics and multi-agent collaboration networks. His ongoing studies delve into password security 🔐, large language models (LLMs) 🧠, and AI-driven educational platforms 🎓, showcasing his dedication to cutting-edge innovation. With a strong research portfolio and a passion for technological advancements, Dr. Cai continues to shape the future of AI and cybersecurity. 🚀

Industry

Beyond academic research, Dr. Yuzhu Cai 🌟 has played a key role in applied technology projects, bridging the gap between innovation and real-world solutions. He contributed to HoneyCloud ☁️🔐, a secure multi-cloud password manager, enhancing cybersecurity practices. Additionally, he was involved in Han Hai Xing Tu 🎓🤖, an AI-driven educational planning platform, revolutionizing personalized learning. His entrepreneurial mindset 💡 and collaborative research efforts strengthen his influence across both academia and industry. With a passion for technological advancement and practical solutions, Dr. Cai continues to drive impactful innovations in AI, security, and education.

Research Focus

Dr. Yuzhu Cai’s research focuses on ensuring the ethical use of AI, particularly in aligning open-source text-to-image models with societal values. In the paper “Ethical-Lens: Curbing Malicious Usages of Open-Source Text-to-Image Models,” Dr. Cai and colleagues introduce Ethical-Lens, a framework designed to prevent the generation of harmful or biased content by these models. This framework operates without altering the internal structures of existing models, instead refining user inputs and adjusting outputs to adhere to ethical standards. By addressing issues like toxicity and bias, Ethical-Lens aims to promote the responsible development and integration of AI tools into society.

Publication Top Notes

Self-evolving multi-agent collaboration networks for software development

Ethical-lens: Curbing malicious usages of open-source text-to-image models